BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30303259)

  • 1. On the reconceptualization of Alzheimer's disease.
    Schermer MHN; Richard E
    Bioethics; 2019 Jan; 33(1):138-145. PubMed ID: 30303259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Views on Early Diagnosis of Alzheimer's Disease Among Dutch Physicians: A Qualitative Interview Study.
    Tromp K; Smedinga M; Richard E; Perry M; Schermer MHN
    J Alzheimers Dis; 2021; 79(2):917-927. PubMed ID: 33361592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Narrative Review of Alzheimer's Disease Stigma.
    Rosin ER; Blasco D; Pilozzi AR; Yang LH; Huang X
    J Alzheimers Dis; 2020; 78(2):515-528. PubMed ID: 33044185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stigmatization in Alzheimer's disease, a review].
    Cavayas M; Raffard S; Gély-Nargeot MC
    Geriatr Psychol Neuropsychiatr Vieil; 2012 Sep; 10(3):297-305. PubMed ID: 23015238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical Disease or Risk Factor? Alzheimer's Disease as a Case Study of Changing Conceptualizations of Disease.
    Schermer MHN
    J Med Philos; 2023 Jun; 48(4):322-334. PubMed ID: 37202835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
    Gauthier S; Leuzy A; Racine E; Rosa-Neto P
    Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for preclinical Alzheimer's disease.
    Tan CC; Yu JT; Tan L
    J Alzheimers Dis; 2014; 42(4):1051-69. PubMed ID: 25024325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical and Social Implications of Using Predictive Modeling for Alzheimer's Disease Prevention: A Systematic Literature Review.
    Angehrn Z; Sostar J; Nordon C; Turner A; Gove D; Karcher H; Keenan A; Mittelstadt B; de Reydet-de Vulpillieres F
    J Alzheimers Dis; 2020; 76(3):923-940. PubMed ID: 32597799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early detection of Alzheimer's disease and approaches for prevention].
    Jessen F
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Mar; 62(3):255-260. PubMed ID: 30680409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Alzheimer's Disease: Implications for Refinement of the Concept.
    Vos SJB; Visser PJ
    J Alzheimers Dis; 2018; 64(s1):S213-S227. PubMed ID: 29865060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Workgroup on NAPA's scientific agenda for a national initiative on Alzheimer's disease.
    Alzheimer's Association Expert Advisory Workgroup on NAPA
    Alzheimers Dement; 2012 Jul; 8(4):357-71. PubMed ID: 22748940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analytic framework for conceptualisations of disease: nine structuring questions and how some conceptualisations of Alzheimer's disease can lead to 'diseasisation'.
    Zeiler K
    Med Health Care Philos; 2020 Dec; 23(4):677-693. PubMed ID: 32770447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease.
    Teipel SJ; Grothe M; Lista S; Toschi N; Garaci FG; Hampel H
    Med Clin North Am; 2013 May; 97(3):399-424. PubMed ID: 23642578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Alzheimer's disease: the next 10 years.
    Hampel H; Prvulovic D; Teipel S; Jessen F; Luckhaus C; Frölich L; Riepe MW; Dodel R; Leyhe T; Bertram L; Hoffmann W; Faltraco F;
    Prog Neurobiol; 2011 Dec; 95(4):718-28. PubMed ID: 22137045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advance directives as a tool to respect patients' values and preferences: discussion on the case of Alzheimer's disease.
    Porteri C
    BMC Med Ethics; 2018 Feb; 19(1):9. PubMed ID: 29458429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of comprehensive Alzheimer's disease centers to address unmet national needs.
    Trojanowski JQ; Arnold SE; Karlawish JH; Brunden K; Cary M; Davatzikos C; Detre J; Gaulton G; Grossman M; Hurtig H; Jedrziewski K; McCluskey L; Naylor M; Polsky D; Schellenberg GD; Siderowf A; Shaw LM; Van Deerlin V; Wang LS; Werner R; Xie SX; Lee VM
    Alzheimers Dement; 2010 Mar; 6(2):150-5. PubMed ID: 20298979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative contributions of disease label and disease prognosis to Alzheimer's stigma: A vignette-based experiment.
    Johnson R; Harkins K; Cary M; Sankar P; Karlawish J
    Soc Sci Med; 2015 Oct; 143():117-27. PubMed ID: 26356823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine Learning Algorithm Helps Identify Non-Diagnosed Prodromal Alzheimer's Disease Patients in the General Population.
    Uspenskaya-Cadoz O; Alamuri C; Wang L; Yang M; Khinda S; Nigmatullina Y; Cao T; Kayal N; O'Keefe M; Rubel C
    J Prev Alzheimers Dis; 2019; 6(3):185-191. PubMed ID: 31062833
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.